PLK1 Antikörper (AA 201-300)
-
- Target Alle PLK1 Antikörper anzeigen
- PLK1 (Polo-Like Kinase 1 (PLK1))
-
Bindungsspezifität
- AA 201-300
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PLK1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunocytochemistry (ICC)
- Kreuzreaktivität
- Human
- Homologie
- Mouse,Rat,Dog,Pig,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human PLK1
- Isotyp
- IgG
- Top Product
- Discover our top product PLK1 Primärantikörper
-
-
- Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
-
Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer." in: Nature communications, Vol. 9, Issue 1, pp. 16, (2018) (PubMed).
: "
-
Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer." in: Nature communications, Vol. 9, Issue 1, pp. 16, (2018) (PubMed).
-
- Target
- PLK1 (Polo-Like Kinase 1 (PLK1))
- Andere Bezeichnung
- PLK1 (PLK1 Produkte)
- Synonyme
- PLK antikoerper, STPK13 antikoerper, plk antikoerper, PLK-1 antikoerper, Plx1 antikoerper, stpk13 antikoerper, Plk antikoerper, cb525 antikoerper, cb636 antikoerper, ik:tdsubc_2d1 antikoerper, wu:fb37g11 antikoerper, wu:fb76g03 antikoerper, xx:tdsubc_2d1 antikoerper, polo like kinase 1 antikoerper, polo like kinase 1 S homeolog antikoerper, polo-like kinase 1 antikoerper, polo-like kinase 1 (Drosophila) antikoerper, Serine/threonine-protein kinase plk-1 antikoerper, PLK1 antikoerper, plk1.S antikoerper, plk1 antikoerper, Plk1 antikoerper, plk-1 antikoerper
- Hintergrund
-
Synonyms: PLK, STPK13, Serine/threonine-protein kinase PLK1, Polo-like kinase 1, PLK-1, Serine/threonine-protein kinase 13, PLK1
Background: PLK1 (polo-like kinase 1) is a member of the serine/threonine protein kinase family, cdc5/polo subfamily. PLK1 contains two polo box domains with a predicted molecular weight of 68 kDa. PLK1 has been shown to regulate cdc2/cyclin B through phosphorylation and activation of cdc25c phosphatase. PLK1 is modified by phosphorylation at Threonine 210. PLK1 may also be required for cell division. Depletion of PLK1 results in apoptosis and deregulation of expression of PKL1 is correlated with development of many malignancies.
- Gen-ID
- 5347
- UniProt
- P53350
- Pathways
- Zellzyklus, M Phase
-